MRI ASSESSMENT OF TUMOR SIZE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY

被引：0
|
作者：
Cuccarini, V. [1 ]
Schettino, C. [2 ,3 ]
Acquino, D. [4 ]
Scotti, A. [4 ]
Cuppini, L. [2 ]
Finocchiaro, G. [2 ]
Bruzzone, M. [4 ]
Eoli, M. [5 ]
机构：
[1] Ist Neurol Besta, Unit Neuroradiol, Milan, Italy
[2] Ist Neurol Besta, Uniti Mol Neurooncol, Milan, Italy
[3] Univ Naples 2, Naples, Italy
[4] Ist Neurol Besta, Uniti Neuroradiol, Milan, Italy
[5] Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02.01
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
    Heugenhauser, Johanna
    Galijasevic, Malik
    Mangesius, Stephanie
    Goebel, Georg
    Buchroithner, Johanna
    Erhart, Friedrich
    Pichler, Josef
    Widhalm, Georg
    Stockhammer, Gunther
    Iglseder, Sarah
    Freyschlag, Christian F.
    Oberndorfer, Stefan
    Bordihn, Karin
    von Campe, Gord
    Czech, Thomas
    Surboeck, Birgit
    Purkart, Tadeja Urbanic
    Marosi, Christine
    Felzmann, Thomas
    Nowosielski, Martha
    CANCERS, 2022, 14 (06)
  • [2] MRI response assessment in glioblastoma patients treated with dendritic cell-based immunotherapy
    Heugenhauser, J.
    Galijasevic, M.
    Mangesius, S.
    Goebel, G.
    Buchroithner, J.
    Erhart, F.
    Pichler, J.
    Widhalm, G.
    Stockhammer, G.
    Iglseder, S.
    Freyschlag, C.
    Oberndorfer, S.
    Bordihn, K.
    Von Campe, G.
    Czech, T.
    Surboeck, B.
    Purkart, T. Urbanic
    Marosi, C.
    Felzmann, T.
    Nowosielski, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 46 - 47
  • [3] DENDRITIC CELL VACCINE IMMUNOTHERAPY IMPROVES SURVIVAL FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Hu, Jethro
    Wheeler, Christopher J.
    Phuphanich, Surasak
    Rudnick, Jeremy
    Nuno, Miriam
    Serrano, Natalia
    Dantis, Jocelynn
    Richardson, Jaime
    Mazer, Mia
    Wang, Hong Qiang
    Chu, Ray
    Black, Keith L.
    Yu, John
    NEURO-ONCOLOGY, 2010, 12 : 33 - 33
  • [4] Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma
    Takei, Jun
    Kamata, Yuko
    Tanaka, Toshihide
    Fukasawa, Nei
    Gomisawa, Kazutaka
    Satake, Mari
    Mori, Ryosuke
    Yamamoto, Yohei
    Suzuki, Tomoya
    Oda, Ayaka
    Murahashi, Mutsunori
    Fukuda, Takahiro
    Shimoda, Masayuki
    Murayama, Yuichi
    Akasaki, Yasuharu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (10) : 3175 - 3189
  • [5] Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
    Van Gool, Stefaan
    De Vleeschouwer, Steven
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (10) : 1173 - 1176
  • [6] Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma
    Jun Takei
    Yuko Kamata
    Toshihide Tanaka
    Nei Fukasawa
    Kazutaka Gomisawa
    Mari Satake
    Ryosuke Mori
    Yohei Yamamoto
    Tomoya Suzuki
    Ayaka Oda
    Mutsunori Murahashi
    Takahiro Fukuda
    Masayuki Shimoda
    Yuichi Murayama
    Yasuharu Akasaki
    Cancer Immunology, Immunotherapy, 2023, 72 : 3175 - 3189
  • [7] Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
    Ardon, Hilko
    Van Gool, Stefaan
    Lopes, Isabel Spencer
    Maes, Wim
    Sciot, Raf
    Wilms, Guido
    Demaerel, Philippe
    Bijttebier, Patricia
    Claes, Laurence
    Goffin, Jan
    Van Calenbergh, Frank
    De Vleeschouwer, Steven
    JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (02) : 261 - 272
  • [8] Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
    Hilko Ardon
    Stefaan Van Gool
    Isabel Spencer Lopes
    Wim Maes
    Raf Sciot
    Guido Wilms
    Philippe Demaerel
    Patricia Bijttebier
    Laurence Claes
    Jan Goffin
    Frank Van Calenbergh
    Steven De Vleeschouwer
    Journal of Neuro-Oncology, 2010, 99 : 261 - 272
  • [9] Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
    Fadul, Camilo E.
    Fisher, Jan L.
    Hampton, Thomas H.
    Lallana, Enrico C.
    Li, Zhongze
    Gui, Jiang
    Szczepiorkowski, Zbigniew M.
    Tosteson, Tor D.
    Rhodes, C. Harker
    Wishart, Heather A.
    Lewis, Lionel D.
    Ernstoff, Marc S.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (04) : 382 - 389
  • [10] Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment against Glioblastoma
    Cuccarini, Valeria
    Aquino, Domenico
    Gioppo, Andrea
    Anghileri, Elena
    Pellegatta, Serena
    Schettino, Carla
    Mazzi, Federica
    Finocchiaro, Gaetano
    Bruzzone, Maria Grazia
    Eoli, Marica
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
12345